Blair William & Co. IL Has $15.73 Million Stake in Align Technology, Inc. (NASDAQ:ALGN)

Blair William & Co. IL lowered its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 46.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 75,449 shares of the medical equipment provider’s stock after selling 65,601 shares during the quarter. Blair William & Co. IL owned about 0.10% of Align Technology worth $15,732,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in ALGN. True Wealth Design LLC lifted its position in shares of Align Technology by 10,700.0% during the third quarter. True Wealth Design LLC now owns 108 shares of the medical equipment provider’s stock worth $27,000 after purchasing an additional 107 shares in the last quarter. Picton Mahoney Asset Management boosted its position in Align Technology by 69.9% in the 4th quarter. Picton Mahoney Asset Management now owns 141 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 58 shares during the last quarter. Neo Ivy Capital Management bought a new position in Align Technology in the 3rd quarter valued at $32,000. Private Trust Co. NA increased its stake in shares of Align Technology by 113.4% in the 4th quarter. Private Trust Co. NA now owns 175 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 93 shares during the period. Finally, Versant Capital Management Inc lifted its stake in shares of Align Technology by 212.2% during the fourth quarter. Versant Capital Management Inc now owns 231 shares of the medical equipment provider’s stock valued at $48,000 after acquiring an additional 157 shares during the period. Institutional investors own 88.43% of the company’s stock.

Align Technology Price Performance

NASDAQ:ALGN opened at $159.21 on Friday. The business’s 50-day simple moving average is $193.72 and its 200-day simple moving average is $214.64. Align Technology, Inc. has a fifty-two week low of $157.57 and a fifty-two week high of $331.64. The stock has a market capitalization of $11.72 billion, a PE ratio of 28.38, a price-to-earnings-growth ratio of 2.24 and a beta of 1.69.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a net margin of 10.54% and a return on equity of 13.84%. On average, research analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on ALGN shares. Piper Sandler reiterated an “overweight” rating and issued a $235.00 price objective (down from $270.00) on shares of Align Technology in a research report on Tuesday, March 18th. Leerink Partners raised shares of Align Technology from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $235.00 to $280.00 in a research note on Monday, January 6th. Mizuho reduced their price objective on shares of Align Technology from $295.00 to $250.00 and set an “outperform” rating on the stock in a research note on Tuesday. Leerink Partnrs upgraded shares of Align Technology from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 6th. Finally, Morgan Stanley reduced their price target on Align Technology from $280.00 to $272.00 and set an “overweight” rating on the stock in a research report on Thursday, February 6th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $262.64.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.